Adapthealth ( (AHCO) ) has released its Q2 earnings. Here is a breakdown of the information Adapthealth presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AdaptHealth Corp. is a leading provider of healthcare-at-home solutions, offering home medical equipment, medical supplies, and related services across the United States. The company operates through segments such as Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually.
In its second quarter of 2025, AdaptHealth reported a slight decrease in net revenue to $800.4 million, down 0.7% from the previous year. The company also saw a decline in net income to $14.7 million and adjusted EBITDA to $155.5 million. Despite these decreases, the company highlighted an increase in cash flow from operations and the successful sale of certain assets.
Key financial metrics showed mixed results, with cash flow from operations increasing to $257.5 million year-to-date, up from $247.0 million in the previous year. However, free cash flow decreased slightly to $73.3 million. The company announced a new capitated partnership with a major national healthcare system, signaling strategic growth initiatives.
AdaptHealth’s management expressed optimism, emphasizing ongoing efforts to enhance operating efficiency, improve patient experience, and expand profit margins. The company is focused on reducing debt and strengthening its financial position, aiming to unlock the full value of its enterprise.
Looking ahead, AdaptHealth has updated its financial guidance for 2025, projecting net revenue between $3.18 billion and $3.26 billion and adjusted EBITDA between $642 million and $682 million. The company remains committed to its strategic initiatives and financial goals, anticipating continued progress in the coming quarters.